Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology
Reference26 articles.
1. Ugwumadu AH, Carmichael PL, Neven P. Tamoxifen and the female genital tract. Int J Gynecol Cancer. 1998;8(1):6–15.
2. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst. 1998;90(18):1371–88.
3. Cohen I. Benign gynecologic conditions in tamoxifen-treated patients. Am J Obstet Gynecol. 2006;194(4):1204–5.
4. Le Donne M, Lentini M, De Meo L, Benedetto V, Mesiti M. Uterine pathologies in patients undergoing tamoxifen therapy for breast cancer: ultrasonographic, hysteroscopic and histological findings. Eur J Gynaecol Oncol. 2005;26:623–6.
5. Yildirim Y, Inal MM, Sanci M, Yildirim YK, Mit T, Polat M, et al. Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of fourcases. Int J Gynecol Cancer. 2005;15:1239–42.